NYSEHealth CareMedical Care FacilitiesSnapshot 2026-07-23
Reading AGL? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
AGL represents a turnaround investment with a focus on improving operational metrics. The current thesis state is intact, as management is on track to achieve positive operating income and increase cash from operations, despite some mixed results in revenue stabilization.
The market appears to have priced in a justified valuation, with AGL being seen as cheap compared to its peers. There is a notable expectations gap, indicating that the market may not fully reflect the potential for improvement in operational performance.
Fundamentals are likely to show continued improvement in operating income and cash flow, as management has consistently prioritized these areas. However, revenue growth stabilization remains a challenge, with limited progress noted in recent quarters.
The long-term thesis hinges on the performance of sector bellwethers like HCA, THC, and DVA, which could influence AGL's trajectory. Additionally, any reversal in guidance from AGL could lead to a credibility issue, impacting investor confidence.
Over the next 1 to 3 years, AGL's performance will depend on its ability to stabilize revenue growth and navigate sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. AGL experienced a sharp drop of 16% recently. This decline suggests the market is reevaluating the reasons to own the stock. The company's fundamentals remain intact, but the price movement indicates a potential issue.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Positive operating income means the company is doing well. This builds trust with investors.
Confirms:Q2 operating income is above $3.997M.
Disproves:Q2 operating income is negative or below $3.997M.
Why it matters: Meeting or exceeding revenue guidance shows the company is stabilizing its growth. This is key for investor confidence.
Confirms:Total revenues reported for Q2 2026 are above $1.435 billion.
Disproves:Total revenues reported for Q2 2026 are below $1.435 billion.
Why it matters: Positive cash flow is crucial for ongoing operations and growth. It shows financial health.
Confirms:Cash from operating activities was more than $23 million.
Disproves:Cash from operating activities was less than $23 million.
Why it matters: Increasing cash flow is crucial for growth. It shows better cash management.
Confirms:Q2 cash from operating activities is over $23.728M.
Disproves:Q2 cash from operating activities falls below $23.728M.
Why it matters: The new CEO's plans can affect investor trust and company success. A good response is important.
Confirms one read:Good comments from analysts or a rise in stock price after the CEO's new plans.
Confirms the other:Bad reactions from analysts or a drop in stock price after the CEO's plans are shared.
Why it matters: New leadership can change company direction. Investors need to understand the new strategy for future growth.
Confirms one read:A press release shares new plans from CEO Tim O'Rourke.
Confirms the other:No updates or clarity on strategic direction from the new CEO.
Why it matters: If the health care sector's revenue growth speeds up, it could help agilon health's performance. This would signal a better market environment.
Confirms:Health care sector revenue growth exceeds 10% year over year.
Disproves:Health care sector revenue growth remains below 10% year over year.
Why it matters: Stabilizing revenue growth is key for long-term success. A drop signals trouble.
Confirms:Q2 revenue growth stabilizes or increases year over year from $1.420B.
Disproves:Q2 revenue declines further year over year from $1.420B.
Why it matters: A new CEO can change company direction. Investor sentiment may shift.
Confirms one read:The market reacted positively. The stock price went up after the CEO announcement.
Confirms the other:The market reacted negatively. The stock price went down after the CEO announcement.
Why it matters: Stable membership numbers show success in keeping members. This helps improve market position.
Confirms:Total members live on the platform reported at 540,000 or higher.
Disproves:Total members live on the platform reported below 540,000.
